Your browser doesn't support javascript.
loading
Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer.
Gaui, Maria de Fátima Dias; Amendola, Luis Claudio; Quintella, Danielle Carvalho; Canedo, Nathalie; Bonomo, Adriana.
Affiliation
  • Gaui MFD; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Departamento de Clínica Médica - Rio de Janeiro (RJ), Brazil.
  • Amendola LC; Instituto Nacional de Saúde da Mulher, Criança e do Adolescente Fernandes Figueira - Rio de Janeiro (RJ), Brazil.
  • Quintella DC; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Departamento de Anatomia Patológica - Rio de Janeiro (RJ), Brazil.
  • Canedo N; Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Departamento de Anatomia Patológica - Rio de Janeiro (RJ), Brazil.
  • Bonomo A; Pesquisadora do Instituto Oswaldo Cruz/Fiocruz - Rio de Janeiro (RJ), Brazil.
Rev Assoc Med Bras (1992) ; 69(9): e20230276, 2023.
Article in En | MEDLINE | ID: mdl-37729362
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Triple Negative Breast Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Programmed Cell Death 1 Receptor / Triple Negative Breast Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2023 Document type: Article Affiliation country: